2072145-36-7
Chemical Structure
3’-beta-Azido-2’,3’-dideoxy-5’-O-(4-methoxy-trityl)uridine
- CAS No.: 2072145-36-7
- Formula:C29H27N5O5
- Molecular Weight:525.56
IUPAC Name: 1-((2R,4R,5S)-4-azido-5-(((4-methoxyphenyl)diphenylmethoxy)methyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
InChIKey: IRQSIJKELRQFIA-RGSZASNESA-N
SMILES: O=C(NC(C=C1)=O)N1[C@@H]2O[C@H](COC(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=C(OC)C=C5)[C@H](N=[N+]=[N-])C2
Biological Activity: 3’-beta-Azido-2’,3’-dideoxy-5’-O-(4-methoxy-trityl)uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3’-beta-Azido-2’,3’-dideoxy-5’-O-(4-methoxy-trityl)uridine | 3’-beta-Azido-2’,3’-dideoxy-5’-O-(4-methoxy-trityl)uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
